Lilly signs licensing agreements with Cipla, Lupin and Sun Pharma for Baricitinib in India EP News Bureau May 10, 2021 Lilly has recently received permission for restricted emergency use by CDSCO for baricitinib to be used in combination with…
NATCO receives emergency-use approval for Baricitinib tablets for COVID-19 treatment EP News Bureau May 3, 2021 Baricitinib, in combination with Remdesivir, is used for treatment of COVID-19-positive patients
